GlassScriptPhysician profile
Adam P Parker
NPI 1477510980
$2,358.09
in general payments reported to CMS, 2019-2025
15 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $23.34 · 2021: $171 · 2022: $554 · 2023: $367 · 2024: $95.14 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677 · Entertainment: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.66 |
| Entertainment | $144.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $654.40 | 2019-2025 | Precision7, Total30, Tryptyr |
| Sun Pharmaceutical Industries INC. | $415.09 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $237.79 | 2019 | |
| Allergan, INC. | $219.47 | 2019-2021 | |
| Oyster Point Pharma, INC. | $197.95 | 2023-2025 | Tyrvaya |
| Optos, INC. | $184.61 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lombart Brothers, INC. | $107.54 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $83.83 | 2022-2025 | Miebo, Infuse, Xiidra |
| Carl Zeiss Meditec USA, INC. | $75.00 | 2022 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $59.42 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.92 | 2019 | |
| Coopervision INC. | $14.82 | 2022 | |
| Abbvie INC. | $14.42 | 2022 | |
| Abb Con-Cise Optical Group LLC | $9.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.